loader image
Friday, November 21, 2025
89.5 F
McAllen
- Advertisement -

No esperes más iVacúnate hoy!

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

The Delta variant is making COVID-19 spread faster and easier, but vaccines help protect you, your family, and the more vulnerable members of your community from becoming seriously ill. #GetVaccinated.

El COVID-19 se ha vuelto aún más peligroso dado a sus variantes, pero las vacunas ayudan a protegerte a ti y a los miembros más vulnerables de tu comunidad. No esperes más. iVacúnate hoy!

Video compartido por Kate del Castillo, más información en MyTurn.ca.gov (833) 422-4233.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Current Heart Attack Screening Tools Are Not Optimal and Fail to Identify Half the People Who Are at Risk

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers.

Don’t Overfill Your Plate or Stomach

We’ve all been there: You’re gathered with family or friends for a delicious holiday meal. You start piling food on your plate, and before you know it, there’s no room left – and you haven’t even made it to the cranberry sauce and sweet potatoes.

UT Health San Antonio Center For Brain Health Celebrates with Ribbon Cutting

University of Texas System and UT San Antonio leaders today hailed “a new era of hope, healing and discovery” for neurological patients and their families with a ribbon-cutting for the UT Health San Antonio Center for Brain Health, a $100 million, 103,000-square-foot facility that will bring specialty care, therapy, diagnostics and research under one ro

Rare Mutation that Predicts Strong Immunotherapy Response in Colorectal Cancer Identified

A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to immunotherapy in patients with metastatic colorectal cancer (CRC).
- Advertisement -
×